CN101897847B - Traditional Chinese medicine for curing asthma - Google Patents

Traditional Chinese medicine for curing asthma Download PDF

Info

Publication number
CN101897847B
CN101897847B CN2009102383572A CN200910238357A CN101897847B CN 101897847 B CN101897847 B CN 101897847B CN 2009102383572 A CN2009102383572 A CN 2009102383572A CN 200910238357 A CN200910238357 A CN 200910238357A CN 101897847 B CN101897847 B CN 101897847B
Authority
CN
China
Prior art keywords
chinese medicine
parts
traditional chinese
asthma
pinellia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102383572A
Other languages
Chinese (zh)
Other versions
CN101897847A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qidong Huilong Vientiane Garden
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102383572A priority Critical patent/CN101897847B/en
Publication of CN101897847A publication Critical patent/CN101897847A/en
Application granted granted Critical
Publication of CN101897847B publication Critical patent/CN101897847B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for curing asthma, belonging to the traditional Chinese field in curing respiratory diseases and aiming to realize good effect and quick curative response. The traditional Chinese medicine is prepared from the following raw materials: Pinellia ternata, lucid ganoderma, tuckahoe, rhizoma atractylodis, pseudo-ginseng, liquorice, Angelica sinensis and the like, which has the functions of strengthening the body resistance and fostering root, nourishing qi and blood, promoting blood circulation and removing blood stasis, warming lung, reducing phlegm and relieving asthma, and has the advantages of obvious effect, definite pesticide effect and quick response.

Description

一种治疗哮喘的中药Chinese medicine for treating asthma

技术领域technical field

本发明属于治疗呼吸病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating respiratory diseases.

背景技术Background technique

目前,旨在治疗哮喘的中药领域,存在着几个方面的不足:一是效果不够明显,二是见效比较迟缓。大批哮喘病患者因药物不能有效治疗和控制该病,以致哮喘反复发作、缠绵难愈,患者常常胸胀气粗、喉中有声、喘不得卧,非常痛苦。患者家属对此很不满意。At present, there are several deficiencies in the field of traditional Chinese medicine aimed at treating asthma: one is that the effect is not obvious enough, and the other is that the effect is relatively slow. A large number of asthma patients cannot effectively treat and control the disease due to drugs, resulting in recurrent attacks of asthma, lingering and difficult to heal. Patients often suffer from chest distension, thick breath, voice in the throat, and difficulty lying down while breathing, which is very painful. The patient's family members were very dissatisfied with this.

针对以上提出的问题,本发明提供一种治疗哮喘的中药,它能解决以往此类中药治疗中效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for treating asthma, which can solve the problem that the effect of traditional Chinese medicines in the past is not obvious enough, and the effect is relatively slow. The advantage of being faster.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗哮喘的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of asthma, adopts Chinese medicine raw material to prepare, and formula is (by weight):

半夏4--30份    灵芝2--12份    茯苓4--30份Pinellia 4-30 parts Ganoderma lucidum 2-12 parts Poria 4-30 parts

苍术4--30份    三七3--20份    甘草3--20份Cangzhu 4--30 parts Sanqi 3--20 parts Licorice 3--20 parts

当归4--30份Angelica 4--30 parts

这种治疗哮喘的中药是由下列方法制成的:This traditional Chinese medicine for asthma is made by the following method:

(1)按上述重量比,将半夏、茯苓、苍术、甘草、当归经常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, Pinellia, Poria, Atractylodes Rhizome, Radix Glycyrrhizae, Angelica Sinensis are extracted through a conventional water extraction process to make extract powder;

(2)按上述重量比,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。本方温肺化痰,专门治疗脾肺阳虚,聚湿生痰止咳喘。方中半夏化痰利气;苍术健脾燥湿,茯苓健脾渗湿;伍以灵芝益气养血,养心安神,扶正培本,增强机体免疫力;当归、三七补血养血,活血化瘀,改善气管和肺组织微循环,甘草益气和中。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀,温肺化痰定喘之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. This prescription warms the lungs and resolves phlegm, and is specially used to treat spleen and lung yang deficiency, accumulation of dampness and phlegm, relieving cough and asthma. Pinellia reduces phlegm and promotes qi; Atractylodes invigorates the spleen and dries dampness; Poria cocos invigorates the spleen and eliminates dampness; Ganoderma lucidum nourishes qi and blood, nourishes the heart and calms the nerves, strengthens the body and strengthens the body's immunity; Angelica and Panax notoginseng nourish blood, Promote blood circulation and remove blood stasis, improve microcirculation of trachea and lung tissue, and licorice tonify qi and neutralize. All the medicines are compatible and complement each other. They play the functions of strengthening the body, nourishing qi and nourishing blood, promoting blood circulation and removing blood stasis, warming the lungs, resolving phlegm and relieving asthma.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

半夏70克    灵芝30克    茯苓70克Pinellia 70g Ganoderma lucidum 30g Poria 70g

苍术70克    三七40克    甘草40克Cangzhu 70g Sanqi 40g Licorice 40g

当归70克Angelica 70g

按规定重量,用常规水提取工艺将半夏、茯苓、苍术、甘草、当归提取,制成浸膏细粉96克,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊592粒,每粒胶囊内含中药细粉及提取物0.28克。According to the prescribed weight, use the conventional water extraction process to extract Pinellia, Poria, Atractylodes Rhizome, Radix Glycyrrhizae, and Angelica to make 96 grams of extract powder, grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, and mix with the above extract fine powder, Stir evenly, make fine particles, pack into No. 0 capsules, and make 592 Chinese medicine capsules, each capsule contains Chinese medicine fine powder and 0.28 grams of extract.

2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):

半夏160克    灵芝60克    茯苓160克Pinellia 160g Ganoderma lucidum 60g Poria 160g

苍术160克    三七90克    甘草160克Cangzhu 160g Sanqi 90g Licorice 160g

当归160克Angelica 160g

按上述同样的方法,制成中药胶囊1317粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1317 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

半夏300克    灵芝120克    茯苓300克Pinellia 300g Ganoderma lucidum 120g Poria 300g

苍术300克    三七200克    甘草200克Cangzhu 300g Sanqi 200g Licorice 200g

当归300克Angelica 300g

按上述同样的方法,制成中药胶囊2642粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 2642 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

4、取以下配方(按重量比):4. Take the following formula (by weight):

半夏8份    灵芝4份    茯苓8份Pinellia 8 parts, Ganoderma lucidum 4 parts, Poria cocos 8 parts

苍术8份    三七6份    甘草6份8 parts of Cangzhu 6 parts of Panax notoginseng 6 parts of licorice

当归8份Angelica 8 servings

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

半夏25份    灵芝8份     茯苓25份Pinellia 25 parts Ganoderma lucidum 8 parts Poria cocos 25 parts

苍术25份    三七15份    甘草15份Cangzhu 25 parts Sanqi 15 parts Licorice 15 parts

当归25份Angelica 25 servings

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医哮喘为例,经7例临床观察。选择中医诊断哮喘为标准:患者肢软乏力,身上没劲;常常胸闷、喘息、咳嗽、呼吸困难;哮喘呈季节性发作,或者冷哮,或者热哮;哮喘时胸胀气粗,声高息涌,喘不得卧。如上症状,即可确诊。在确诊观察的对象中,男性5例,女性2例,无其它严重疾病,年龄为45岁-78岁,平均年龄71.1岁。The present invention takes asthma of traditional Chinese medicine as an example, through clinical observation of 7 cases. Choose the criteria for the diagnosis of asthma in traditional Chinese medicine: the patient's limbs are weak and weak, and his body is dull; he often has chest tightness, wheezing, coughing, and dyspnea; asthma is a seasonal attack, or cold wheezing, or hot wheezing; Do not lie down. The above symptoms can be diagnosed. Among the confirmed observation objects, there were 5 males and 2 females, without other serious diseases, aged from 45 to 78 years old, with an average age of 71.1 years old.

疗效判定:Judgment of curative effect:

1、显效:体质增强,身上有劲;胸闷、咳嗽、呼吸困难明显缓解;哮喘发作次数减少,时间较短;提前2个月服用,冷哮或热哮发作几率降低。1. Significant effect: physical fitness is enhanced, body is strong; chest tightness, cough, and dyspnea are significantly relieved; the number of asthma attacks is reduced and the time is shorter; taking it 2 months in advance reduces the chance of cold or hot asthma attacks.

2、有效:体质增强,身上有劲;胸闷、喘息、咳嗽、呼吸困难有所缓解。2. Effective: Physical fitness is enhanced, body is strong; chest tightness, wheezing, coughing, and dyspnea are relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日2次,每次5粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,1个月后症状即有缓解,服用3个月后,症状明显改善。临床实验的7人中,显效3人,有效3人,无效1人,总有效率85.7%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 2 times a day, 5 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 1 month, and after 3 months of taking, Symptoms improved significantly. Among the 7 people in the clinical trial, 3 people were markedly effective, 3 people were effective, and 1 person was ineffective, and the total effective rate was 85.7%.

Claims (1)

1.一种治疗哮喘的中药,其特征在于,所述中药是采用中药原料制备,中药原料的重量配比为:1. a kind of Chinese medicine for the treatment of asthma, is characterized in that, described Chinese medicine is to adopt Chinese medicine raw material to prepare, and the weight proportion of Chinese medicine raw material is: 半夏4——30份        灵芝2——12份        茯苓4——30份Pinellia 4-30 parts Ganoderma lucidum 2-12 parts Poria 4-30 parts 苍术4——30份        三七3——20份        甘草3——20份Cangzhu 4—30 parts Sanqi 3—20 parts Licorice 3—20 parts 当归4——30份Angelica 4 - 30 servings 这种治疗哮喘的中药是由下列方法制成的:This traditional Chinese medicine for asthma is made by the following method: (1)按上述重量比将半夏、茯苓、苍术、甘草、当归经常规水提取工艺提取,制成浸膏细粉;(1) Pinellia, Poria cocos, Atractylodes atractylodes, Radix Glycyrrhizae, Radix Angelicae Sinensis are extracted by conventional water extraction process according to the above weight ratio, and made into extract powder; (2)按上述重量比,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀;制成中药颗粒剂、散剂、胶囊剂、水丸剂、片剂。(2) According to the above weight ratio, grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, mix with the above extract powder, and stir evenly; make traditional Chinese medicine granules, powders, capsules, water pills, and tablets.
CN2009102383572A 2009-11-25 2009-11-25 Traditional Chinese medicine for curing asthma Expired - Fee Related CN101897847B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102383572A CN101897847B (en) 2009-11-25 2009-11-25 Traditional Chinese medicine for curing asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102383572A CN101897847B (en) 2009-11-25 2009-11-25 Traditional Chinese medicine for curing asthma

Publications (2)

Publication Number Publication Date
CN101897847A CN101897847A (en) 2010-12-01
CN101897847B true CN101897847B (en) 2011-09-28

Family

ID=43223987

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102383572A Expired - Fee Related CN101897847B (en) 2009-11-25 2009-11-25 Traditional Chinese medicine for curing asthma

Country Status (1)

Country Link
CN (1) CN101897847B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102885948A (en) * 2012-09-18 2013-01-23 遵义臻坤中草医药研究所 Chinese medicinal composition for treating upper respiratory tract infection and bronchial asthma and preparation method for Chinese medicinal composition

Also Published As

Publication number Publication date
CN101897847A (en) 2010-12-01

Similar Documents

Publication Publication Date Title
CN101843699A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN102824623A (en) Chinese medicinal prescription for treating bronchitis
CN101530461B (en) Traditional Chinese medicine for treating nasopharyngeal cancer
CN103933480A (en) Traditional Chinese medicament for treating phthisis
CN103251864A (en) Chinese medicament for treating pneumonia and preparation method thereof
CN101884731B (en) Traditional Chinese medicine for treating silicosis
CN101897847B (en) Traditional Chinese medicine for curing asthma
CN101530490B (en) Traditional Chinese medicine for treating bladder cancer
CN101564505B (en) Chinese medicament for treating pulmonary heart disease
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101884704B (en) Traditional Chinese medicine for treating asthma
CN102389547A (en) Traditional Chinese medicine for treating diabetic foot
CN101843738A (en) Chinese medicament for treating diabetic feet
CN101843830B (en) Chinese medicament for treating pulmonary heart diseases
CN101850079B (en) Chinese medicament for treating asthma
CN101850017B (en) Chinese medicament for treating asthma
CN101850083B (en) Chinese medicament for treating asthma
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843718B (en) Chinese medicament for treating lupus erythematosus
CN101396454B (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN102389474A (en) Chinese medicine for treating diabetic constipation
CN101843844B (en) Chinese medicament for treating pulmonary heart diseases
CN101396468B (en) A kind of traditional Chinese medicine for treating diabetic coronary heart disease
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: QIDONG HUILONG WANXIANG FLOWER NURSERY

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20131108

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226299 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20131108

Address after: Qidong huilongzhen 54 226299 villages in Jiangsu province Nantong City Service Center (south side)

Patentee after: Qidong Huilong Vientiane Garden

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110928